Clinical Experience With CSAI for Parkinson Disease

Video content above is prompted by the following:

Clinical Experience With Infusion Systems

Experience with Continuous Subcutaneous Apomorphine Infusion (CSAI) and Other Infusions:

• Learning curve for both clinicians and patients
• Initial intensive monitoring period crucial for success
• Importance of team-based approach to management
• Technical challenges with devices gradually resolved with experience
• Patient selection critically impacts outcomes

Incorporation Into Existing Treatment Plans:

• Gradual introduction alongside existing oral medications
• Individualized titration based on symptom response
• Maintenance of morning oral medication is often beneficial
• Combination with low-dose oral therapy for overnight symptom control
• Careful monitoring during transition period

Adjusting Levodopa and Other Medications:

• Systematic reduction based on observed response to infusion
• Typically, 30% to 50% reduction in oral levodopa dose initially
• Complete elimination of certain adjunctive medications possible
• Individual titration based on symptom diaries and clinical assessment
• Maintaining minimum necessary oral medications to optimize benefit-risk ratio

Lessons From European CSAI Experience:

• Importance of dedicated nursing support for successful implementation
• Need for thorough patient education and expectation management
• Value of standardized protocols for initiation and troubleshooting
• Strategic management of common adverse effects improves adherence
• Multidisciplinary approach improves outcomes and patient satisfaction